Previously, we reported that polymorphonuclear leukocytes (PMNs) from the peritoneal cavity of mice could kill murine tumour cells in vitro on addition of appropriate mediators such as plant lectins Tsunawaki et al., 1983) , animal lectins , antitumour antibody , anticancer chemotherapeutic drugs and immunomodulators (Morikawa et al., 1985b) . Purified PMNs (99.1-99.5%) also showed cytolytic activity . Some non-protein factor such as hydrogen peroxide produced by PMNs is involved in the lytic process with immunomo-dulators (Morikawa et al., 1985a) and preliminary studies showed that a protein factor from PMNs participated in other types of killing ; in other words, a PMN-derived factor can lyse tumour cells in co-operation with wheat germ agglutinin or actinomycin D. In this work, we investigated the character of a PMN-derived cytotoxin. This paper reports that not only macrophages, but also inflammatory PMNs can produce a cytotoxin and that PMNs may produce this cytotoxin in vivo.
Inbred male C3H/He and DDY mice were obtained from Shizuoka Experimental Animal Farm (Shizuoka, Japan). Polymorphonuclear leukocytes (PMNs) were prepared as described previously . Briefly, 2ml of 12% casein solution was injected into the peritoneal cavity of mice and the peritoneal exudate was harvested 6h later, passed through nylon mesh and centrifuged at 300g for 5min. The cells were washed twice with RPMI-1640 medium (Nissui Seiyaku Co., Tokyo) supplemented with 100 U ml-1 of penicillin (Banyu Pharmaceutical Co., Tokyo) and 100 gml-P of streptomycin (Meiji Seika Co., Tokyo). Usually, the peritoneal cells were suspended in RPMI-1640 medium containing 5% heat-inactivated foetal calf serum (Gibco, Grand Island, NY; called medium hereafter the absorbance of the supernatant at 590 nm was measured in a photometer (Myreader 7, Sanko Junyaku Co., Tokyo). Cytolytic activity was calculated as follows:
The dilution of the sample giving the half survival ratio (ED50) was obtained from a dose-response curve. Cytolytic activity (units) was calculated as the ratio of the ED50 of the culture supernatant to that of rabbit tumour necrosis serum (Abe et al., 1985) in each test plate. The cytolytic activity of this rabbit tumour necrosis serum was equivalent to 6 x 103 units of recombinant human TNF.
We reported previously that direct contact between effector PMNs and target tumour cells is not essential for tumour lysis and that lysis involves a protein factor from the PMNs . Since the protein factor alone was not cytolytic to tumour cells, the cytolysis seemed to be induced by a combination of a factor from the PMNs and actinomycin D, and the PMNs seemed to release this factor spontaneously into the medium.
Lipopolysaccharide (LPS) stimulates the release of cytolytic factors such as tumour necrosis factor (TNF) from macrophages. Therefore, we examined whether LPS enhanced the release of cytotoxin from PMNs. Table I shows that LPS augmented the release of cytotoxin from macrophages, but not from PMNs. These results suggest that casein-induced peripheral PMNs are fully activated for cytotoxin release without any additional stimulation, and that the mechanisms of cytotoxin release from macrophages and PMNs may be different.
The culture supernatants of PMNs and macrophages were subjected to high performance liquid chromatography (HPLC) to estimate the molecular weights of the cytotoxins. The cytotoxin from PMNs was mainly eluted in the fraction corresponding to a molecular weight of about 70kDa with a shoulder of material of about 50kDa (Figure la) . The cytotoxin released from BCG-induced macrophages was eluted in the fraction of about 50kDa (Figure lb) . Thus the cytotoxins from PMNs and macrophages differ in molecular weight.
PMNs accumulate at the site of inflammation, so, to determine whether the cytotoxin was detectable in vivo, we examined the cytotoxic activity of inflammatory ascitic fluid. PMNs accumulate at the site of injection of casein or fl-1-3-D-glucan from Alcaligenes faecalis (Morikawa et al., 1984) . As shown in Figure 2 , ascitic fluid obtained from the peritoneal cavity after infiltration of PMNs showed cytotoxic activity even at a concentration of 1%. Cytotoxic activity in the ascitic fluid appeared 3-6h after casein injection with accumulation of PMNs and then gradually disappeared with time (data not shown).
On HPLC, the cytotoxin from inflammatory ascites was mainly eluted in the fraction of about 70 kDa with a shoulder of about 50kDa (Figure lc) like the cytotoxin from PMNs (Figure la) . These data suggest that the cytotoxin may be released from PMNs into the inflammatory ascites in vivo.
C The Macmillan Press Ltd., 1989 Br. J. Cancer (1989 Fraction number Figure 1 HPLC profiles of cytotoxin in supernatants from 5h cultures of PMNs (a) and macrophages incubated with LPS (b). The concentrated supernatants and cell-free ascites (c) were subjected to HPLC (Shimadzu, LC-6A) on a 0.75 x 60cm column of G3000SW (Toyo Soda Manufacturing Co.). Arrows indicate molecular weights of standards.
Most previous studies on the cytotoxicity of PMNs have been focused on oxygen metabolites. PMNs have been shown to kill tumour cells through oxygen-dependent pathways (Clark & Klevanoff, 1979; Dallegri et al., 1983; Nathan et al., 1979) . We also reported that hydrogen peroxide was an effector molecule in immunomodulatordependent PMN-mediated tumour lysis (Morikawa et 1985a). However, the present PMN factor was not an oxygen metabolite such as hydrogen peroxide; it seemed to be a protein, because it was heat-labile and was inactivated by trypsin .
This spontaneously relased cytotoxin was antigenically indistinguishable from TNF from macrophages (data not shown), so it may be a TNF-like molecule or TNF itself. However, its release from PMNs was not stimulated by LPS (Table I) , which enhances release of TNF from macrophages, and its molecular weight was different from that of TNF from macrophages (Figure 1) . This TNF-like cytotoxin was present in inflammatory ascites in vivo as well as being relased spontaneously in vitro (Figures 1 and 2) . Inflammatory PMNs probably contain a TNF-like cytotoxin and release it locally in vivo, since recent studies (Beuther & Cerami, 1986; Old, 1987) have indicated that TNF is an endogenous mediator of inflammation. In fact, TNF has been reported to induce chemotaxis (Ming et al., 1987) and production of oxygen metabolites by phagocytes.
Recently, TNF has been found in leukocytes (Cuturi et al., 1987) , NK cells (Degliantoni et al., 1985) and fibroblasts (Rubin et al., 1986) . We also found that bone marrow cells released a TNF-like cytotoxin (Okutomi et al., 1987) . Therefore, TNF is not a specific product of monocytes/ macrophages. PMNs are phagocytic and inflammatory cells, and can produce interleukin-l (Yoshinaga et al., 1985) , oxygen metabolites (Clark & Klevanoff, 1979) and platelet activating factor (Lother et al., 1980) 
